关注
Taoufiq Harach
Taoufiq Harach
在 epfl.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
A Cattaneo, N Cattane, S Galluzzi, S Provasi, N Lopizzo, C Festari, ...
Neurobiology of aging 49, 60-68, 2017
11102017
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ...
Scientific reports 7 (1), 41802, 2017
7822017
Germ‐free C57BL/6J mice are resistant to high‐fat‐diet‐induced insulin resistance and have altered cholesterol metabolism
S Rabot, M Membrez, A Bruneau, P Gérard, T Harach, M Moser, ...
The FASEB Journal 24 (12), 4948-4959, 2010
7442010
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading
TWH Pols, M Nomura, T Harach, GL Sasso, MH Oosterveer, C Thomas, ...
Cell metabolism 14 (6), 747-757, 2011
5732011
Porphyrias
UA Meyer
Harrison's principles of internal medicine, 1829-1834, 1991
1941991
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
T Harach, TWH Pols, M Nomura, A Maida, M Watanabe, J Auwerx, ...
Scientific reports 2 (1), 430, 2012
1922012
Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis
PJ Fernandez-Marcos, EH Jeninga, C Canto, T Harach, VCJ De Boer, ...
Scientific reports 2 (1), 425, 2012
1442012
LRH-1–dependent glucose sensing determines intermediary metabolism in liver
MH Oosterveer, C Mataki, H Yamamoto, T Harach, N Moullan, ...
The Journal of clinical investigation 122 (8), 2817-2826, 2012
1252012
Lo Sasso G, Oosterveer MH, Thomas C, Rizzo G, Gioiello A, Adorini L, Pellicciari R, Auwerx J, Schoonjans K. TGR5 activation inhibits atherosclerosis by reducing macrophage …
TW Pols, M Nomura, T Harach
Cell Metab 14 (6), 747-757, 2011
982011
Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet
T Harach, O Aprikian, I Monnard, J Moulin, M Membrez, JC Béolor, ...
Planta medica 76 (06), 566-571, 2010
982010
Role of TGR5 (GPBAR1) in liver disease
V Keitel, D Häussinger
Seminars in liver disease 38 (04), 333-339, 2018
892018
Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease
T Harach, F Jammes, C Muller, N Duthilleul, V Cheatham, V Zufferey, ...
Neurobiology of aging 51, 83-96, 2017
822017
Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice [S]
C Thabuis, F Destaillats, DM Lambert, GG Muccioli, M Maillot, T Harach, ...
Journal of lipid research 52 (7), 1373-1382, 2011
492011
lo Sasso
TW Pols, M Nomura, T Harach
G, 0
47
Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota
T Harach, N Marungruang, N Dutilleul, V Cheatham, KD Mc Coy, ...
arXiv preprint arXiv:1509.02273, 2015
382015
Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ...
Scientific reports 7 (1), 46856, 2017
322017
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep. 2017; 7: 41802
T Harach, N Marungruang, N Duthilleul, V Cheatham, KD Mc Coy, ...
Epub 2017/02/09. https://doi. org/10.1038/srep41802 PMID: 28176819, 1802
251802
Gastro-Intestinal Biomarkers for Diagnosis and Therapies of Proteinopathies
T Lasser, T Bolmont, T Harach, W Hanna, F Fåk, N Marungruang
US Patent App. 15/541,045, 2017
2017
Use of waste products for detecting amyloidogenic proteinaceous material in living mammals
T Bolmont, P Fraering, T Lasser, M Dimtrov, T Harach
2013
Crossroads between drug and energy metabolism: role of constitutive androstane receptor and AMP-activated kinase
T Harach
University_of_Basel, 2010
2010
系统目前无法执行此操作,请稍后再试。
文章 1–20